J&J Unit Loses Out To Medtronic In Stent Case

Law360, New York (March 23, 2006, 12:00 AM EST) -- In a big upset for Johnson & Johnson, an arbitration panel has ruled that a Medtronic Inc. coronary stent does not infringe on its rival’s patents, giving Medtronic the opportunity to take a large bite out of the $5 billion global stent market.

The independent panel found Wednesday that Medtronic’s Driver stent did not violate a 1997 settlement and cross-license agreement with patents of Johnson & Johnson’s Cordis unit.

The arbitration panel found its devices were licensed under the agreement between Medtronic and Cordis for the...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.